Myelodysplastic Syndrome With Excess Blasts Clinical Trials

16 clinical trials for Myelodysplastic Syndrome With Excess Blasts across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome — RECRUITING · PHASE2
• Personalized NK Cell Therapy in CBT — RECRUITING · PHASE2
• TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes With Increased Blasts — RECRUITING · PHASE1
• 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome — RECRUITING · PHASE1
• 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia — RECRUITING · PHASE1
• A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS — RECRUITING · PHASE1
• Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome — RECRUITING · PHASE2
• Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia — ACTIVE_NOT_RECRUITING · PHASE1
• Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia — ACTIVE_NOT_RECRUITING · PHASE2
• Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm — ACTIVE_NOT_RECRUITING · PHASE2
• Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission — COMPLETED · PHASE3
• Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes — ACTIVE_NOT_RECRUITING · PHASE2
• Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD — COMPLETED · PHASE2
• Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers — TERMINATED · PHASE2
• Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma — COMPLETED · PHASE2
• Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia — COMPLETED · PHASE2

Refine this search